Extendicare Inc. (OTCMKTS:EXETF – Get Free Report)’s stock price was up 1.1% during mid-day trading on Friday . The stock traded as high as $11.65 and last traded at $11.64. Approximately 515 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 12,908 shares. The stock had previously closed at $11.51.
Wall Street Analyst Weigh In
Several research analysts have recently commented on EXETF shares. CIBC assumed coverage on Extendicare in a report on Monday, September 22nd. They set an “outperform” rating on the stock. BMO Capital Markets restated a “market perform” rating on shares of Extendicare in a research report on Monday, August 11th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold”.
Read Our Latest Report on Extendicare
Extendicare Price Performance
Extendicare Cuts Dividend
The business also recently declared a dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a $0.0303 dividend. This represents a dividend yield of 358.0%. The ex-dividend date of this dividend was Tuesday, September 30th. Extendicare’s payout ratio is -185.01%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Articles
- Five stocks we like better than Extendicare
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Transportation Stocks Investing
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- 5 discounted opportunities for dividend growth investors
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
